• Releases new Cardiology Report feature in CONNEQT App
• Provides personalized insights into heart and arterial health
• Enables users to track cardiovascular indicators and identify risks

Cardiex Limited (ASX: CDX) has announced the release of a significant new feature in its CONNEQT App - the Cardiology Report. This latest update enhances the app's capabilities by providing users with a comprehensive cardiovascular health assessment, delivering personalized insights into heart and arterial health over time. The Cardiology Report translates clinically validated cardiovascular biomarkers, derived from over 20 years of research, into an easy-to-understand digital format, bringing advanced arterial health and central blood pressure insights directly to consumers. Designed for individuals focused on proactive heart health management, the Cardiology Report enables users to track key cardiovascular indicators, identify potential risks early, and make informed lifestyle or medical decisions in consultation with healthcare professionals. Through periodic reports and trend analyses, users gain actionable intelligence traditionally only available in clinical settings. This new feature is expected to drive higher user engagement within the CONNEQT App, by offering visually intuitive reports and risk assessments that encourage ongoing cardiovascular monitoring. Additionally, it establishes the foundation for future in-app monetization opportunities, including premium reports and guided health programs, as Cardiex continues to expand its consumer health ecosystem.

The launch of the Cardiology Report in the CONNEQT App is expected to drive higher user engagement and establish the foundation for future in-app monetization opportunities, including premium reports and guided health programs.

Cardiex remains committed to translating its clinically validated cardiovascular metrics into accessible consumer tools, further enhancing its mission to improve heart health outcomes through innovative technology.